全文获取类型
收费全文 | 994篇 |
免费 | 59篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 47篇 |
妇产科学 | 64篇 |
基础医学 | 87篇 |
口腔科学 | 122篇 |
临床医学 | 84篇 |
内科学 | 192篇 |
皮肤病学 | 18篇 |
神经病学 | 116篇 |
特种医学 | 31篇 |
外科学 | 114篇 |
综合类 | 6篇 |
预防医学 | 45篇 |
眼科学 | 47篇 |
药学 | 44篇 |
中国医学 | 1篇 |
肿瘤学 | 26篇 |
出版年
2024年 | 1篇 |
2023年 | 15篇 |
2022年 | 27篇 |
2021年 | 63篇 |
2020年 | 39篇 |
2019年 | 42篇 |
2018年 | 57篇 |
2017年 | 44篇 |
2016年 | 52篇 |
2015年 | 50篇 |
2014年 | 67篇 |
2013年 | 73篇 |
2012年 | 110篇 |
2011年 | 77篇 |
2010年 | 28篇 |
2009年 | 39篇 |
2008年 | 50篇 |
2007年 | 43篇 |
2006年 | 57篇 |
2005年 | 38篇 |
2004年 | 27篇 |
2003年 | 20篇 |
2002年 | 15篇 |
2001年 | 5篇 |
2000年 | 6篇 |
1999年 | 5篇 |
1997年 | 2篇 |
1995年 | 1篇 |
1991年 | 1篇 |
1989年 | 1篇 |
1987年 | 1篇 |
1970年 | 1篇 |
排序方式: 共有1057条查询结果,搜索用时 31 毫秒
111.
Merigueti Yslla Fernanda Fitz Balo da Silva Raposo Ricardo Zampieri Bianca Pelegi de Lima Cerazo Letícia Maria Pereira Ludimilla Santarém Vamilton Alvares 《Parasitology research》2018,117(11):3481-3486
Parasitology Research - Toxocariasis is an important, but neglected, worldwide zoonosis. It is considered a primarily soil-transmitted disease, but food-borne transmission has been associated with... 相似文献
112.
113.
Husniye Demirturk Kocasarac Ayse Burcu Altan Canan Yerlikaya Alper Sinanoglu Marcel Noujeim 《Acta odontologica Scandinavica》2017,75(2):79-86
Objective: To assess the correlation between third molar mineralization (TMM), spheno-occipital synchondrosis (SOS) fusion, chronologic age and cervical vertebrae maturation (CVM) for skeletal maturation.Materials and methods: Radiographs for 116 patients between 8 and 28 years were evaluated for age determination using mandibular TMM, SOS fusion and CVM. Spearman Correlation and Kappa test analyses were used to assess the relationship between variables and for intraobserver reliability.Results: Strong correlation was found between chronological age and TMM for males (r?=?.802) and females (r?=?.842), very strong correlation was found between age and CVM for males (r?=?.812) and moderate for females (r?=?.449), it was strong between age and SOS fusion for males (r?=?.810) and females (r?=?.643). Correlation between TMM and SOS was found to be strong for males (r?=?.759) and moderate for females (r?=?.534), it was strong between TMM and CVM for males (r?=?.723) and weak for females (r?=?.371). Very strong correlation was found between CVM and SOS fusion for males (r?=?.851) and strong correlation for females (r?=?.618).Conclusion: Good correlation was found between the degrees of TMM, fusion of SOS and CVM in young Turkish population. 相似文献
114.
Combined methylphenidate and atomoxetine pharmacotherapy in attention deficit hyperactivity disorder
Burcu Ozbaran Sezen Kose Onur Yuzuguldu Burcu Atar Cahide Aydin 《The world journal of biological psychiatry》2015,16(8):619-624
Object?ves. Pharmacological treatment of attention deficit hyperactivity disorder (ADHD) includes stimulant and non-stimulant medications. Our purpose in this study is to investigate efficacy, safety and tolerability of combined methylphenidate and atomoxetine pharmacotherapy. Methods. We included 12 patients of the 824 patients with ADHD using methylphenidate and atomoxetine combined therapy between the years 2010 and 2014. Kiddie-SADS, Turgay DSM-IV Based Child and Adolescent Behavior Disorders Screening and Rating Scale, Child Behavior Checklist, Clinic Global Impression Scale Severity and Impression (CGIS-S-I) scales were used. Results. Patients were between the ages of 7 and 17 years. Before combined pharmacotherapy the CGIS-S score mean was 5.08. Mean CGIS-S score after the combined pharmacotherapy was 3.08 (P = 0.03; –2,980). The most common side effects were irritability (n = 5, 41.6%), appetite reduction (n = 3, 25%), palpitations (n = 2, 16.7%), headache (n = 1, 8.3%). Conclus?ons. Nine of these 12 patients showed significant improvement in their symptoms, combined therapy enhanced the effectiveness of monotherapy. 相似文献
115.
116.
Oral flurbiprofen spray for mucosal graft harvesting at the palatal area: A randomized placebo‐controlled study
下载免费PDF全文
![点击此处可从《Journal of periodontology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Sila Cagri Isler Nihal Eraydin Habibe Akkale Burcu Ozdemir 《Journal of periodontology》2018,89(10):1174-1183
1 Background
Flurbiprofen which is a non‐steroidal anti‐inflammatory drug (NSAID), has been safely used for the control of postoperative patient's morbidity after periodontal plastic surgeries requiring palatal graft harvesting, but there is little information on the efficacy of topical use. The aim of the study was to evaluate whether patient pain perception was reduced and patient morbidity was improved by using oral spray of flurbiprofen after palatal graft harvesting.2 Methods
Forty‐eight patients (21 males and 27 females), scheduled for subepithelial connective tissue graft (SCTG) and free gingival graft (FGG) requiring periodontal plastic surgeries were selected. The patients were randomly assigned to each group and used oral spray of flurbiprofen or placebo three times a day for a week. The palatal donor area was evaluated at 1, 3, 7, 14, 21, 28, 42, and 56‐day follow‐up after the surgery for postoperative pain, patients’ discomfort, complete epithelialization, changes in dietary habits, burning sensation, color match, the amount of systemic analgesic consumption and the presence of delayed bleeding. Wound healing scores were recorded at 14‐day follow up.3 Results
The prevalance of complete epithelialization was significantly higher in the placebo‐FGG group than flurbiprofen‐FGG group at 21 days postoperatively (P < 0.05), while there was no significant alteration for both flurbiprofen‐SCTG and placebo‐SCTG groups at any follow‐up periods. In flurbiprofen‐FGG group, significant improvements were observed for postoperative pain, patients’ discomfort and burning sensation at 14 days postoperatively (P < 0.05).4 Conclusion
Oral flurbiprofen spray reduces patient's morbidity, however it might have negative effects on epithelialization of secondary wound healing after FGG operations. 相似文献117.
Caroline Conway Lucy Stead Catherine Daly Rebecca Chalkley Stefano Berri Burcu Senguven Lisa Ross Philip Egan Preetha Chengot Thian K. Ong Monica Pentenero Sergio Gandolfo Adele Cassenti Paola Cassoni Abdulaziz Al Ajlan Alaa Samkari William Barrett Kenneth MacLennan Alec High Pamela Rabbitts 《International journal of cancer. Journal international du cancer》2015,137(10):2364-2373
118.
119.
Murat KARKUCAK Burcu YÜCEL Mehmet SÖNMEZ Ahmet ALVER Neşe KAKLIKKAYA Mehmet TOSUN Emel ALEMDAROĞLU Mustafa SOLAK 《International journal of rheumatic diseases》2012,15(6):538-545
Aim: The aim of this study was to investigate the associations between human leukocyte antigen (HLA)‐DRB1 alleles with genetic susceptibility to rheumatoid arthritis (RA) and production of antibodies against cyclic citrullinated peptide (anti‐CCP antibody) and rheumatoid factor (RF) in Turkish RA patients. Methods: We studied 291 RA patients and 253 controls. Genotyping was performed by polymerase chain reaction with sequence‐specific oligonucleotide probes hybridization method. Serum levels of anti‐CCP antibody, IgM‐RF and high sensitive C‐reactive protein titers were measured by commercial kits using immunological methods. Results: We found that HLA‐DRB1*04 and *09 alleles were associated in anti‐CCP+ and anti‐CCP+ RA patients (P < 0.0001 and P < 0.001, respectively), while DRB1*01 and *04 were determined to be higher in RF+ RA patients (P < 0.001 and P < 0.0001, respectively). Moreover, DRB1*11 and DRB1*13 alleles were determined to be lower in RF and anti‐CCP/RF+ RA patients (P < 0.001 for both). HLA‐DRB1*04 was identified as a common responsible allele for susceptibility to the disease in anti‐CCP, RF and anti‐CCP/RF? RA patients (P = 0.0018, P = 0.0004 and P = 0.0023, respectively). HLA‐DRB1*13 allele alone was found to be protective against to anti‐CCP+ and RF? RA (P = 0.0003 and P = 0.006, respectively). On the contrary, there was no protective allele in anti‐CCP/RF? RA as well as anti‐CCP? RA patients. Conclusion: This study indicates that associate and protective HLA‐DRB1 allele distributions are different in autoantibody (anti‐CCP or RF or anti‐CCP/RF)+ RA and autoantibody? RA patients, with exceptions of DRB1*04 and DRB1*13. 相似文献
120.